Department of Medicine, Jacobs School of Medicine, Divisions of Behavioral Medicine and Gastroenterology, University at Buffalo, Buffalo, NY, USA.
School of Social Work, New York University, New York, NY, USA.
Am J Gastroenterol. 2019 Feb;114(2):330-338. doi: 10.1038/s41395-018-0396-x.
BACKGROUND: There is a need for safe and effective IBS treatments that provide immediate and sustained improvement of IBS symptoms, particularly among more severe patients. The aim was to assess long-term clinical response of cognitive behavioral therapy (CBT) with reference to IBS education. METHODS: A total of 436 Rome III-diagnosed IBS patients (80% F, M age = 41 years) were randomized to: 4 session home-based CBT (minimal contact (MC-CBT)), 10 session clinic-based CBT (standard (S-CBT)), or 4 session IBS education (EDU). Follow-up occurred at 2 weeks and 3, 6, 9, and 12 months following treatment completion. Treatment response was based a priori on the Clinical Global Improvement Scale (global IBS symptom improvement) and IBS Symptom Severity Scale (IBS-SSS). RESULTS: Post-treatment CGI gains were generally maintained by MC-CBT patients at quarterly intervals through 12-month follow-up with negligible decay. For MC-CBT and S-CBT, 39 and 33% of respondents maintained treatment response at every follow-up assessment. The corresponding percent for EDU was 19%, which was significantly lower (p < 0.05) than for the CBT groups. On the IBS-SSS, therapeutic gains also showed a pattern of maintenance with trends towards increased efficacy over time in all conditions, with the mean unit reductions between baseline and follows-up being approximately -76 at immediate and approximately -94 at 12 months (-50 = clinically significant). CONCLUSIONS: For treatment-refractory IBS patients, home- and clinic-based CBT resulted in substantial and enduring relief of multiple IBS symptoms that generally extended to 12-month post treatment.
背景:需要安全有效的 IBS 治疗方法,以提供对 IBS 症状的即时和持续改善,特别是针对更严重的患者。本研究旨在评估认知行为疗法(CBT)与 IBS 教育相结合的长期临床疗效。
方法:共有 436 名罗马 III 诊断的 IBS 患者(80%为女性,平均年龄为 41 岁)被随机分为三组:4 次家庭为基础的认知行为疗法(最小接触(MC-CBT))、10 次诊所为基础的认知行为疗法(标准(S-CBT))或 4 次 IBS 教育(EDU)。治疗完成后 2 周及 3、6、9 和 12 个月进行随访。根据临床总体改善量表(整体 IBS 症状改善)和 IBS 症状严重程度量表(IBS-SSS)来评估治疗反应。
结果:MC-CBT 患者在治疗后每隔三个月进行一次随访,CGI 评分的改善情况基本保持稳定,且下降幅度可以忽略不计。对于 MC-CBT 和 S-CBT,39%和 33%的患者在每次随访中均保持治疗反应,而 EDU 组的这一比例为 19%,显著低于 CBT 组(p<0.05)。在 IBS-SSS 上,治疗效果也呈现出保持的趋势,所有条件下的疗效均随时间推移而增加,在基线和随访之间的平均单位减少约为 -76,在 12 个月时约为 -94(-50 表示具有临床意义)。
结论:对于治疗抵抗的 IBS 患者,家庭和诊所为基础的 CBT 可显著持久地缓解多种 IBS 症状,且这种缓解效果通常可以持续到治疗后 12 个月。
Lancet Gastroenterol Hepatol. 2019-9-3
Clin Gastroenterol Hepatol. 2010-2-17
Clin Gastroenterol Hepatol. 2018-10-26
Neurogastroenterol Motil. 2021-11
J Neurogastroenterol Motil. 2025-4-30
Curr Gastroenterol Rep. 2024-11
Signal Transduct Target Ther. 2023-12-6
World J Gastroenterol. 2023-7-14
Nat Commun. 2023-6-13
N Engl J Med. 2017-6-29
Nat Rev Dis Primers. 2016-3-24
Clin Gastroenterol Hepatol. 2013-3-21
Clin Gastroenterol Hepatol. 2010-2-17